Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004251930 | SCV003869642 | uncertain significance | not specified | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.1412C>A (p.S471Y) alteration is located in exon 12 (coding exon 11) of the IGFN1 gene. This alteration results from a C to A substitution at nucleotide position 1412, causing the serine (S) at amino acid position 471 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |